Protein kinase R (PKR) expression as a predictive factor for interferon response in chronic hepatitis C patients / Mai Muhammed Ragab ; Supervised Magdy Ali Amin , Amal Ahmed Mohamed
Material type:
- نسبة وجود جين بروتين كايناز كدليل على مدى استجابة مرضى الالتهاب الكبدى الوبائى المزمن سى للعلاج بالانترفيرون [Added title page title]
- Issued also as CD
Item type | Current library | Home library | Call number | Copy number | Status | Barcode | |
---|---|---|---|---|---|---|---|
![]() |
قاعة الرسائل الجامعية - الدور الاول | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.08.06.M.Sc.2013.Ma.P (Browse shelf(Opens below)) | Not for loan | 01010110061142000 | ||
![]() |
مخـــزن الرســائل الجـــامعية - البدروم | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.08.06.M.Sc.2013.Ma.P (Browse shelf(Opens below)) | 61142.CD | Not for loan | 01020110061142000 |
Thesis (M.Sc.) - Cairo University - Faculty of Pharmacy - Department of Microbiology and Immunology
Egypt has the highest prevalence of hepatitis C virus (HCV) worldwide . Currently combined pegylated interferon and ribavirin therapy are the standard treatment . The biological activity of interferon (IFN) is mediated by the induction of intracellular antiviral proteins, such as 2'-5' oligoadenylate synthetase, and dsRNA - activated protein kinase. IFN inducible double - stranded RNA- activated protein kinase (PKR) is thought to play a key antiviral role against HCV
Issued also as CD
There are no comments on this title.